Solventum Corporation Releases Transcript of BofA 2025 Healthcare Conference Presentation

Reuters
16 May
<a href="https://laohu8.com/S/SOLV">Solventum</a> Corporation Releases Transcript of BofA 2025 Healthcare Conference Presentation

Solventum Corporation recently published a transcript from their participation in the BofA Securities 2025 Healthcare Conference, which took place on May 13, 2025, at 2:20 p.m. PDT. The event featured Bryan Hanson, Chief Executive Officer, and Wayde McMillan, Chief Financial Officer of Solventum, alongside Bank of America Analyst Travis Steed. During the conference, the Solventum executives reflected on the company's progress since becoming a public entity a year ago. Bryan Hanson noted, "It's actually hard to believe it was only a year ago that we spun, because so much has happened." He highlighted the unexpectedly rapid transformation within the market, which has allowed the company to raise its guidance for the year. Wayde McMillan discussed the company's growth, stating, "Even the 2.5%, we think is a good strong growth rate. It's more than double what we grew in all of 2024." He also elaborated on the challenges related to the separation and ERP implementation, expressing confidence in the team handling these processes. The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solventum Corporation published the original content used to generate this news brief on May 16, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10